Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. Cash on Hand 2023–2025
Entrada Therapeutics Inc. annual cash on hand history from 2023 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Entrada Therapeutics Inc. cash on hand as of December 31, 2025: 90.4M, a 10.69% decrease year-over-year.
- Entrada Therapeutics Inc. cash on hand for 2025 were 90.4M, a 10.69% decrease from 2024.
- Entrada Therapeutics Inc. cash on hand for 2024 were 101.2M, a 49.72% increase from 2023.
- Entrada Therapeutics Inc. cash on hand for 2023 were 67.6M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Entrada Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $90 |
| 2024 | $101 |
| 2023 | $68 |
Entrada Therapeutics Inc. Cash on Hand — FAQ
Entrada Therapeutics Inc. (TRDA) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRDA's cash on hand history?
The chart and table above show Entrada Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.